Recombinant Human CD300g/Nepmucin Fc Chimera Protein, CF

Catalog # Availability Size / Price Qty
10615-NE-050
Recombinant Human CD300g/Nepmucin Fc Chimera Protein Bioactivity.
2 Images
Product Details
FAQs
Reviews

Recombinant Human CD300g/Nepmucin Fc Chimera Protein, CF Summary

Product Specifications

Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Level
<1.0 EU per 1 μg of the protein by the LAL method.
Activity
Measured by its ability to inhibit anti-CD3 antibody induced IL-2 or IFN-gamma secretion by human T cells. The ED50 for this effect is 0.5-5 μg/mL.
Source
Mouse myeloma cell line, NS0-derived human CD300g/Nepmucin protein
Human CD300g/Nepmucin
(Leu19-Leu249)
Accession # AAH25395.1
IEGRMD Human IgG1
(Pro100-Lys330)
N-terminusC-terminus
Accession #
N-terminal Sequence
Analysis
Leu19
Structure / Form
Disulfide-linked homodimer
Predicted Molecular Mass
52 kDa
SDS-PAGE
68-97 kDa, under reducing conditions.

Product Datasheets

You must select a language.

x

10615-NE

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

10615-NE

Formulation Lyophilized from a 0.2 μm filtered solution in PBS.
Reconstitution Reconstitute at 200 μg/mL in PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Scientific Data

Bioactivity View Larger

Measured by its ability to inhibit anti-CD3 antibody induced IFN-gamma secretion by human T cells. The ED50 for this effect is 0.5-5 μg/mL.

SDS-PAGE View Larger

2 μg/lane of Recombinant Human CD300g/Nepmucin Fc Chimera Protein (Catalog # 10615-NE) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing bands at 68-97 kDa and 140-200 kDa, respectively.

Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: CD300g/Nepmucin

Nepmucin, also known as CMRF35-like molecule 9 (CLM-9), TREM-4 and CD300g, is a 75-95 kDa type I transmembrane O-glycosylated member of the CD300 family of molecules. Nepmucin (mucin not expressed in Peyer's Patches) is expressed on capillary endothelium and its expression appears to be influenced by factors that are locally produced in tissues (1, 2). Nepmucin contains a single V-type immunoglobulin domain and a mucin-like domain (3). Mature human nepmucin is composed of 314 amino acid (aa), containing 229 aa extracellular domain (ECD), a 21 aa transmembrane segment, and a 64 aa cytoplasmic region. Within the ECD, human nepmucin shares 53% aa identity with mouse nepmucin. Nepmucin plays a critical role in promoting lymphocyte transendothelial migration of high endothelial veins and mediates lymphocyte adhesion with endothelial cells by its Ig domain, which is independent of LFA-1 or VLA-4 adhesion pathway (3). Glycosylated nepmucin with MECA-79 epitope associate with L-selectin to mediate L-selectin-dependent lymphocyte rolling by its mucin-like domain (4). Expression of nepmucin is down-regulated in tumours and tumour-draining lymph nodes, indicating that the expression of nepmucin is negatively regulated by locally produced signals under these circumstances (2). Nepmucin induction can significantly improve the killing activity of CIK cells (5).

References
  1. Jin, S. et al. (2008) FEBS Lett. 582:3018.
  2. Umemoto, E. et al. (2013) PloS One. 8:e83681.
  3. Umemoto, E. et al. (2006) J. Exp. Med. 203:1603.
  4. Takatsu H, et al. (2006) Biochem. Biophys. Res. Commun. 348:183.
  5. Wang, Q. et al. (2017) Cent. Eur. J. Immunol. 42:117.
Entrez Gene IDs
146894 (Human); 52685 (Mouse); 684984 (Rat)
Alternate Names
CD300 antigen like family member G; CD300 antigen-like family member G; CD300 molecule like family member g; CD300 molecule-like family member g; CD300g antigen; CD300g; CD300LG; CLM9; CLM-9; CLM9Trem4; CMRF35-like molecule 9; Nepmucin; TREM4; TREM-4; Triggering receptor expressed on myeloid cells 4

FAQs

No product specific FAQs exist for this product, however you may

View all Proteins and Enzyme FAQs

Reviews for Recombinant Human CD300g/Nepmucin Fc Chimera Protein, CF

There are currently no reviews for this product. Be the first to review Recombinant Human CD300g/Nepmucin Fc Chimera Protein, CF and earn rewards!

Have you used Recombinant Human CD300g/Nepmucin Fc Chimera Protein, CF?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review